Abstract Objective To dynamically observe the changes in hypoxia-inducible factor 1α (HIF-1α) and Bcl-2/adenovirus E1B19kDa-interacting protein 3 (BNIP3) in children with traumatic brain injury (TBI) and evaluate their clinical value in predicting the severity and prognosis of pediatric TBI. Methods A prospective study included 47 children with moderate to severe TBI from January 2021 to July 2023, categorized into moderate (scores 9-12) and severe (scores 3-8) subgroups based on the Glasgow Coma Scale. A control group consisted of 30 children diagnosed and treated for inguinal hernia during the same period, with no underlying diseases. The levels of HIF-1α, BNIP3, autophagy-related protein Beclin-1, and S100B were compared among groups. The predictive value of HIF-1α, BNIP3, Beclin-1, and S100B for the severity and prognosis of TBI was assessed using receiver operating characteristic (ROC) curves. Results Serum levels of HIF-1α, BNIP3, Beclin-1, and S100B in the TBI group were higher than those in the control group (P<0.05). Among the TBI patients, the severe subgroup had higher levels of HIF-1α, BNIP3, Beclin-1, and S100B than the moderate subgroup (P<0.05). Correlation analysis showed that the serum levels of HIF-1α, BNIP3, Beclin-1, and S100B were negatively correlated with the Glasgow Coma Scale scores (P<0.05). After 7 days of treatment, serum levels of HIF-1α, BNIP3, Beclin-1, and S100B in both non-surgical and surgical TBI patients decreased compared to before treatment (P<0.05). ROC curve analysis indicated that the areas under the curve for predicting severe TBI based on serum levels of HIF-1α, BNIP3, Beclin-1, and S100B were 0.782, 0.835, 0.872, and 0.880, respectively (P<0.05), and for predicting poor prognosis of TBI were 0.749, 0.775, 0.814, and 0.751, respectively (P<0.05). Conclusions Serum levels of HIF-1α, BNIP3, and Beclin-1 are significantly elevated in children with TBI, and their measurement can aid in the clinical assessment of the severity and prognosis of pediatric TBI.
ZHU Lei,WANG Xue-Cheng,XU Yan-Yan et al. Expression and significance of hypoxia-inducible factor 1α and Bcl-2/adenovirus E1B19kDa-interacting protein 3 in children with traumatic brain injury[J]. CJCP, 2024, 26(4): 378-384.
ZHU Lei,WANG Xue-Cheng,XU Yan-Yan et al. Expression and significance of hypoxia-inducible factor 1α and Bcl-2/adenovirus E1B19kDa-interacting protein 3 in children with traumatic brain injury[J]. CJCP, 2024, 26(4): 378-384.
Li S, Zhao J, Xi Y, et al. Dl-3-n-butylphthalide exerts neuroprotective effects by modulating hypoxia-inducible factor 1-alpha ubiquitination to attenuate oxidative stress-induced apoptosis[J]. Neural Regen Res, 2023, 18(11): 2424-2428. PMID: 37282472. PMCID: PMC10360089. DOI: 10.4103/1673-5374.371366.
Lin C, Li L, Xu Q, et al. Yap1-Usp14 axis inhibits neuronal mitophagy during neonatal hypoxia-ischemia encephalopathy by regulation of beclin-1 ubiquitination in mouse[J]. Mol Neurobiol, 2023, 60(8): 4273-4287. PMID: 37062801. DOI: 10.1007/s12035-023-03344-5.
Lai Z, Li C, Ma H, et al. Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes[J]. J Ethnopharmacol, 2023, 308: 116268. PMID: 36842723. DOI: 10.1016/j.jep.2023.116268.
Velle F, Lewén A, Howells T, et al. Cerebral pressure autoregulation and optimal cerebral perfusion pressure during neurocritical care of children with traumatic brain injury[J]. J Neurosurg Pediatr, 2023, 31(5): 503-513. PMID: 36804198. DOI: 10.3171/2023.1.PEDS22352.
Esteban-Zubero E, García-Muro C, Alatorre-Jiménez MA. Fluid therapy and traumatic brain injury: a narrative review[J]. Med Clin (Barc), 2023, 161(1): 27-32. PMID: 37031064. DOI: 10.1016/j.medcli.2023.03.003.
Navarrete C, García-Martín A, Correa-Sáez A, et al. A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury[J]. J Neuroinflammation, 2022, 19(1): 177. PMID: 35810304. PMCID: PMC9270745. DOI: 10.1186/s12974-022-02540-9.
Xiong A, Li J, Xiong R, et al. Inhibition of HIF-1α-AQP4 axis ameliorates brain edema and neurological functional deficits in a rat controlled cortical injury (CCI) model[J]. Sci Rep, 2022, 12(1): 2701. PMID: 35177771. PMCID: PMC8854620. DOI: 10.1038/s41598-022-06773-9.
Mu J, Weng J, Yang C, et al. Necrostatin-1 prevents the proapoptotic protein Bcl-2/adenovirus E1B 19-kDa interacting protein 3 from integration into mitochondria[J]. J Neurochem, 2021, 156(6): 929-942. PMID: 32112403. DOI: 10.1111/jnc.14993.
Suo Y, Zhang L, Che Y. IL-4 alleviates CIRI by suppressing autophagy via the HIF-1α/Bcl-2/BNIP3 pathway in rats[J]. Acta Neurobiol Exp (Wars), 2023, 83(3): 246-254. PMID: 37874193. DOI: 10.55782/ane-2023-2429.
Demirci E, Tastepe N, Gul MK, et al. S100B and neuron-specific enolase levels as brain injury biomarkers in internet addiction: effect of sleep[J]. Pediatr Neurol, 2023, 149: 93-99. PMID: 37837757. DOI: 10.1016/j.pediatrneurol.2023.08.029.
Marzano LAS, Batista JPT, de Abreu Arruda M, et al. Traumatic brain injury biomarkers in pediatric patients: a systematic review[J]. Neurosurg Rev, 2022, 45(1): 167-197. PMID: 34170424. DOI: 10.1007/s10143-021-01588-0.
WANG Cai-Yun, XU Hong-Mei, LIU Gang, LIU Jing, YU Hui, CHEN Bi-Quan, ZHENG Guo, SHU Min, DU Li-Jun, XU Zhi-Wei, HUANG Li-Su, LI Hai-Bo, WANG Dong, BAI Song-Ting, SHAN Qing-Wen, ZHU Chun-Hui, TIAN Jian-Mei, HAO Jian-Hua, LIN Ai-Wei, LIN Dao-Jiong, WU Jin-Zhun, ZHANG Xin-Hua, CAO Qing, TAO Zhong-Bin, CHEN Yuan, ZHU Guo-Long, XUE Ping, TANG Zheng-Zhen, SU Xue-Wen, QU Zheng-Hai, ZHAO Shi-Yong, PANG Lin, DENG Hui-Ling, SHU Sai-Nan, CHEN Ying-Hu. A multi-center epidemiological study on pneumococcal meningitis in children from 2019 to 2020[J]. CJCP, 2024, 26(2): 131-138.